427 results
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
of its long-term ambitions or priorities laid out in its corporate strategy; Gilead’s ability to accelerate or sustain revenues for its virology … assets
Liabilities and Stockholders’ Equity
Current liabilities
Long-term liabilities
Stockholders’ equity(1)
Total liabilities and stockholders
SC TO-T
EX-99
pfvc8pa nlocwy9ovl
23 Feb 24
Third party tender offer statement
6:09am
8-K
EX-99.1
r5eo10m6iurz1
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
EX-99.1
m69 6pi2d
7 Nov 23
Gilead Sciences Announces Third Quarter 2023 Financial Results
4:03pm
424B5
67pvpxh6x 19
11 Sep 23
Prospectus supplement for primary offering
4:09pm
424B5
1h6tihk4y2uqdw4q9d6
7 Sep 23
Prospectus supplement for primary offering
8:29am
8-K
EX-99.1
30ha19pdj2ieyw
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
8-K
EX-99.1
2xpob3a
27 Apr 23
Gilead Sciences Announces First Quarter 2023 Financial Results
4:05pm
CORRESP
yhsusw zghi
25 Apr 23
Correspondence with SEC
12:00am
8-K
EX-99.1
vusu6h 13luz4
27 Oct 22
Gilead Sciences Announces Third Quarter 2022 Financial Results
4:04pm